Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus- infected cells

Journal of Infectious Diseases

Volumn 174, Issue 5, 1996, Pages 1105-1108

  Kohl, Steve ^a,b   Sigaroudinia, Mahvash ^a   Charlebois, Edwin D ^a   Jacobson, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0029969108     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.5.1105     Document Type: Article

References (12)

1. Brunda MJ. Interleukin-12. J Leukoc Biol 1994;55:280-8.
2. Chehimi J, Valiante NM, D'Andrea A, et al. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 1993;23:1826-30.
3. Bonavida B, Katz J, Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cell, and partial restoration by IL-2. J Immunol 1986;137:1157-63.
4. Chehimi J, Starr SE, Frank I, et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992;175:789-96.
5. Jenkins M, Mills J, Kohl S. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults. Pediatr Res 1993;33:469-74.
6. Tyler DS, Stanley SD, Nastala CA, et al. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. J Immunol 1990;144:3375-84.
7. Cesano A, Visonneau S, Clark SC, Santoli D. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol 1993;151:2943-57.
8. Robertson MJ, Soiffer RJ, Wolf SF, et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992;175:779-88.
9. + T cell clones from HIV-infected patients. J Clin Invest 1995;96:1677-82.
10. + T lymphocytes. J Immunol 1995;155:111-7.
11. Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol 1995;154:5144-52.
12. Ling P, Gately MK, Grubler U, et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995;154:116-27.